780
Views
5
CrossRef citations to date
0
Altmetric
Report

Characterization of a variety of neutralizing anti-heparin-binding epidermal growth factor-like growth factor monoclonal antibodies by different immunization methods

, , , , &
Pages 732-739 | Published online: 24 Sep 2012

References

  • Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 1992; 267:6205 - 12; PMID: 1556128
  • Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251:936 - 9; http://dx.doi.org/10.1126/science.1840698; PMID: 1840698
  • Kobrin MS, Funatomi H, Friess H, Buchler MW, Stathis P, Korc M. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1994; 202:1705 - 9; http://dx.doi.org/10.1006/bbrc.1994.2131; PMID: 8060360
  • Mishima K, Higashiyama S, Asai A, Yamaoka K, Nagashima Y, Taniguchi N, et al. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Acta Neuropathol 1998; 96:322 - 8; http://dx.doi.org/10.1007/s004010050901; PMID: 9796995
  • Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, et al. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res 2004; 64:5720 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-04-0811; PMID: 15313912
  • Naef M, Yokoyama M, Friess H, Büchler MW, Korc M. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. Int J Cancer 1996; 66:315 - 21; http://dx.doi.org/10.1002/(SICI)1097-0215(19960503)66:3<315::AID-IJC8>3.0.CO;2-1; PMID: 8621250
  • Thøgersen VB, Sørensen BS, Poulsen SS, Orntoft TF, Wolf H, Nexo E. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res 2001; 61:6227 - 33; PMID: 11507076
  • Hoffmann AC, Danenberg KD, Taubert H, Danenberg PV, Wuerl P. A three-gene signature for outcome in soft tissue sarcoma. Clin Cancer Res 2009; 15:5191 - 8; http://dx.doi.org/10.1158/1078-0432.CCR-08-2534; PMID: 19671876
  • Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, et al. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin Cancer Res 2005; 11:4783 - 92; http://dx.doi.org/10.1158/1078-0432.CCR-04-1426; PMID: 16000575
  • Hamaoka M, Chinen I, Murata T, Takashima S, Iwamoto R, Mekada E. Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding. J Biochem 2010; 148:55 - 69; http://dx.doi.org/10.1093/jb/mvq033; PMID: 20332144
  • Khong TF, Fraser S, Katerelos M, Paizis K, Hill PA, Power DA. Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis. Kidney Int 2000; 58:1098 - 107; http://dx.doi.org/10.1046/j.1523-1755.2000.00267.x; PMID: 10972674
  • Miyamoto S, Iwamoto R, Furuya A, Takahashi K, Sasaki Y, Ando H, et al. A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells. Clin Cancer Res 2011; 17:6733 - 41; http://dx.doi.org/10.1158/1078-0432.CCR-11-1029; PMID: 21918176
  • Stollar BD, Fuchs S, Mozes E. Immune response of mice to nucleic acids: strain-dependent differences in magnitude and class of antibody production. J Immunol 1973; 111:121 - 9; PMID: 4576583
  • Hoffenbach A, Lagrange PH, Bach MA. Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium. Cell Immunol 1985; 91:1 - 11; http://dx.doi.org/10.1016/0008-8749(85)90026-7; PMID: 3882240
  • Kasai K, Teuscher C, Smith S, Matzner P, Tung KS. Strain variations in anti-sperm antibody responses and anti-fertility effects in inbred mice. Biol Reprod 1987; 36:1085 - 94; http://dx.doi.org/10.1095/biolreprod36.5.1085; PMID: 3620556
  • Baraldo K, Mori E, Bartoloni A, Petracca R, Giannozzi A, Norelli F, et al. N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines. Infect Immun 2004; 72:4884 - 7; http://dx.doi.org/10.1128/IAI.72.8.4884-4887.2004; PMID: 15271954
  • Defendini ML, Pierres M, Regnier-Vigouroux A, Rochat H, Granier C. Epitope mapping of apamin by means of monoclonal antibodies raised against free or carrier-coupled peptide. Mol Immunol 1990; 27:551 - 8; http://dx.doi.org/10.1016/0161-5890(90)90074-A; PMID: 1696354
  • Karle S, Nishiyama Y, Taguchi H, Zhou YX, Luo J, Planque S, et al. Carrier-dependent specificity of antibodies to a conserved peptide determinant of gp120. Vaccine 2003; 21:1213 - 8; http://dx.doi.org/10.1016/S0264-410X(02)00504-2; PMID: 12559800
  • Amagai M. Autoimmune and infectious skin diseases that target desmogleins. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86:524 - 37; http://dx.doi.org/10.2183/pjab.86.524; PMID: 20467217
  • Ladner RC. Mapping the epitopes of antibodies. Biotechnol Genet Eng Rev 2007; 24:1 - 30; PMID: 18059626
  • Swartzman EE, Miraglia SJ, Mellentin-Michelotti J, Evangelista L, Yuan PM. A homogeneous and multiplexed immunoassay for high-throughput screening using fluorometric microvolume assay technology. Anal Biochem 1999; 271:143 - 51; http://dx.doi.org/10.1006/abio.1999.4128; PMID: 10419629
  • Defize LH, Boonstra J, Meisenhelder J, Kruijer W, Tertoolen LG, Tilly BC, et al. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors. J Cell Biol 1989; 109:2495 - 507; http://dx.doi.org/10.1083/jcb.109.5.2495; PMID: 2553748
  • Lax I, Bellot F, Howk R, Ullrich A, Givol D, Schlessinger J. Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. EMBO J 1989; 8:421 - 7; PMID: 2785915
  • Lax I, Fischer R, Ng C, Segre J, Ullrich A, Givol D, et al. Noncontiguous regions in the extracellular domain of EGF receptor define ligand-binding specificity. Cell Regul 1991; 2:337 - 45; PMID: 1716463
  • Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002; 110:775 - 87; http://dx.doi.org/10.1016/S0092-8674(02)00963-7; PMID: 12297050
  • Jin P, Zhang J, Beryt M, Turin L, Brdlik C, Feng Y, et al. Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands. Mol Med 2009; 15:11 - 20; http://dx.doi.org/10.2119/molmed.2008.00103; PMID: 19048033
  • Giorgio C, Hassan Mohamed I, Flammini L, Barocelli E, Incerti M, Lodola A, et al. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation. PLoS One 2011; 6:e18128; http://dx.doi.org/10.1371/journal.pone.0018128; PMID: 21479221
  • Beerli RR, Hynes NE. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem 1996; 271:6071 - 6; http://dx.doi.org/10.1074/jbc.271.11.6071; PMID: 8626392
  • Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971; 8:871 - 4; http://dx.doi.org/10.1016/0019-2791(71)90454-X; PMID: 5135623

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.